These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5556742)

  • 21. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Work of the committee on drug side effects].
    Naes K
    Tidsskr Nor Laegeforen; 1975 Aug; 95(22):1237-8. PubMed ID: 1162664
    [No Abstract]   [Full Text] [Related]  

  • 23. [Create or strengthen the drug committee at a hospital].
    Bruneton C
    Med Trop (Mars); 2006 Dec; 66(6):569-72. PubMed ID: 17286023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Achieving rational therapeutics through consensus-based protocols and follow-up.
    Quintiliani R; Gousse GC; Chow MS
    Hosp Formul; 1990 Mar; 25(3):283-4, 289-94. PubMed ID: 10103836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can drug utilization help in promoting the more rational use of medicine? Experiences from Western Nepal.
    Shankar PR; Mishra P; Subish P; Upadhyay DK
    Pak J Pharm Sci; 2007 Jul; 20(3):243-48. PubMed ID: 17545111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developing policy for handling investigational drugs.
    Ebel JA
    Hosp Manage; 1967 Aug; 104(2):58-64. PubMed ID: 6073958
    [No Abstract]   [Full Text] [Related]  

  • 27. Rational drug use (II): Hospital drug and therapeutics committees.
    Manyemba J; Dzuda C; Nyazema NZ
    Cent Afr J Med; 2000 Sep; 46(9):256-9. PubMed ID: 11320773
    [No Abstract]   [Full Text] [Related]  

  • 28. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse drug reactions and the P & T committee.
    Lipman AG
    Hosp Formul; 1980 Jul; 15(7):580. PubMed ID: 10247654
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the utilization coefficient for drugs].
    Bonda J
    Pharm Prax; 1966; 7():165-7. PubMed ID: 6001090
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug and therapeutics committees: the relationships among structure, function, and effectiveness.
    Plumridge RJ; Stoelwinder JU; Rucker TD
    Hosp Pharm; 1993 Jun; 28(6):492-3, 496-8, 508. PubMed ID: 10126453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacy committees and the prescription of drugs].
    Boréus LO
    Lakartidningen; 1969 Jun; 66():Suppl II:44+. PubMed ID: 5384122
    [No Abstract]   [Full Text] [Related]  

  • 33. Implementation of an intravenous potassium policy.
    Cooper BE
    Hosp Pharm; 1989 Jun; 24(6):462-4. PubMed ID: 10293974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hospital essential drugs in Africa. An example of pharmacoeconomic research].
    Meillon C; Stum N; Cuisinier-Raynal JC
    Dakar Med; 1996; Spec No():19-20. PubMed ID: 14520980
    [No Abstract]   [Full Text] [Related]  

  • 35. P & T Committee rises to challenges of the changing healthcare environment.
    Eybel CE; Pierpaoli PG; Carasiti ME
    Hosp Formul; 1991 Nov; 26(11):886-8, 890-4. PubMed ID: 10114819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of tetracycline.
    J Iowa Med Soc; 1980 Aug; 70(8):333-4, 346. PubMed ID: 7400637
    [No Abstract]   [Full Text] [Related]  

  • 37. Twenty years' experience with drug information centers.
    Amerson AB; Wallingford DM
    Am J Hosp Pharm; 1983 Jul; 40(7):1172-8. PubMed ID: 6881155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Drug Spotlight Program.
    Aagaard GN
    J Assoc Hosp Med Educ; 1978; 1st Quarter():58-60. PubMed ID: 10307276
    [No Abstract]   [Full Text] [Related]  

  • 39. IV push policy: the economic effects of IV drug administration guidelines.
    Hughes TE; Suzuki NT
    Hosp Formul; 1986 Jul; 21(7):793-9, 802. PubMed ID: 10317755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing an effective P&T Committee, Part I.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Jul; 20(7):827-8, 837, 841-3 passim. PubMed ID: 10271920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.